HIV, Pregnancy and a Digital Comic Integrated Care Model for HIV/STI Prevention and HCV Treatment Initiation in a Residential SUD Treatment Program: Current Practices and Challenges Expansion of HIV Pre-Exposure Prophylaxis Utilizing Pharmacy-led Clinic at Veterans Affairs Health-System Multidisciplinary Management of Substance Use Disorder in People Living with HIV treated in a Medical Home Model of Care Increased Patient Adherence to Pre-exposure Prophylaxis (PrEP) after Implementation of a Pharmacy Supported PrEP Program PrEP use trend and assessment of factors that may affect PrEP persistence Clinical Pharmacy: PrEPing for the Future of HIV Prevention at a Large Academic Veterans Affairs Medical Center Implementing a standard operating procedure for PrEP increased provider comfort, knowledge and prescribing in a Georgia residency program Characteristics of Early Adopters of a Two-Drug Regimen (Dolutegravir/Lamivudine) for Treatment of Human Immunodeficiency Virus Type 1 (HIV-1) in a Real-World Setting Prevalence of Polypharmacy and Medication use Contraindicated during Pregnancy among a Cohort of Women Living with HIV who are of Childbearing Age, 2016-2017 Cabotegravir + Rilpivirine Every 2 Months is Noninferior to Monthly: Atlas-2M Study Headache and Lung Mass in the HIV Positive PatientFeasibility, Efficacy, and Safety of Using Dolutegravir/Lamivudine (DTG/3TC) as a First-Line Regimen in a Test-and-Treat Setting for Newly Diagnosed People Living with HIV (PLWH): The STAT Study
